We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Integrated Blood Collector Estimates Radiation Exposure

By MedImaging International staff writers
Posted on 30 Oct 2019
Print article
Image: The integrated blood collector (Photo courtesy of the University of Arizona – Phoenix).
Image: The integrated blood collector (Photo courtesy of the University of Arizona – Phoenix).
A new study describes how a compact blood self-collection device can quickly estimate exposure to radiation in the event of a nuclear accident or attack.

Developed at Columbia University (New York, NY, USA), the University of Arizona College of Medicine (Phoenix, USA), and Georgetown University (Washington, DC, USA), the device is comprised of miniaturized vacuum tube coupled with integrated capillaries and a lancet that together form a self-collection device that can process blood specimens of 100 μl for analysis of the cytogenetic and gene expression biodosimetry responses of circulating lymphocytes. The analysis itself is undertaken in a centralized bioanalytical laboratory, with results returned after one day in the gene expression tests, and three days with the cytogenic tests.

The miniaturized vacuum tube system facilitates liquid reagent storage, simple operation, and reduced sample contamination. The shelf life has been extended beyond one year by including low temperature storage, a Parylene barrier coating, and container vacuum bag sealing. Collected blood samples showed similar behavior in terms of gene expression and cytogenetic biodosimetry assays when compared to traditionally collected samples. According to the researchers, the new device could alleviate the sample collection bottleneck for radiation countermeasures following a large-scale nuclear event. The study was published on October 16, 2019, in PLOS One.

“Biological dosimetry determines the extent of damage to DNA caused by ionizing radiation associated with an acute exposure of a dirty bomb or nuclear accident. In ionizing radiation, electrons are knocked out of atoms and form charged particles,” said lead author Jian Gu, PhD, of the University of Arizona. “In a nuclear event, hundreds of thousands of people would need to be screened in a very short time, and traditional medical infrastructure for blood collection may not be available.”

There are two basic types of biodosimetry, with different, often complementary characteristics. The first is based on changes in biological parameters, such as gene activation or chromosomal abnormalities, while the second is based on physical tissue changes. Biodosimetry methods include chromosome aberration frequencies, as identified from fluorescence in situ hybridization (FISH) of peripheral blood lymphocytes, and electron paramagnetic resonance (EPR) measurements made on tooth enamel.

Related Links:
Columbia University
University of Arizona College of Medicine
Georgetown University

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Compact C-Arm
Arcovis DRF-C S21
New
Ultrasound Table
Ergonomic Advantage (EA) Line
New
Ceiling-Mounted Digital Radiography System
Radiography 5000 C

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)

New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients

Clear cell renal cell cancer (ccRCC) represents 70-80% of renal cell carcinoma cases. While localized disease can be effectively treated with surgery and ablative therapies, one-third of patients either... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.